CC
IDXX icon

CQS Cayman’s Idexx Laboratories IDXX Stock Holding History

CQS Cayman’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.4M Buy
+19,863
New +$5.53M 0.24% 72

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CQS Cayman's IDXX Position: Q3 2019 in Review

CQS Cayman opened a new position in Idexx Laboratories (IDXX) in Q3 2019: 19,863 shares worth $5.4M. The stake represents 0.24% of the portfolio and ranks #72 among its holdings.

719 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

  • CQS Cayman held 19,863 shares of Idexx Laboratories worth $5.4M as of Q3 2019.
  • Idexx Laboratories was a new CQS Cayman position in Q3 2019.
  • Idexx Laboratories made up 0.24% of CQS Cayman's portfolio in Q3 2019, its #72 holding.
  • 719 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on CQS Cayman's 13F filing for Q3 2019, filed 12 Nov 2019.